KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $3.3 billion.

  • Teva Pharmaceutical Industries' Cash & Current Investments fell 33.62% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 billion, marking a year-over-year decrease of 20.63%. This contributed to the annual value of $3.3 billion for FY2024, which is 2.29% up from last year.
  • Teva Pharmaceutical Industries' Cash & Current Investments amounted to $3.3 billion in FY2024, which was up 2.29% from $3.2 billion recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Cash & Current Investments ranged from a high of $3.3 billion in FY2024 and a low of $2.2 billion during FY2021.
  • In the last 3 years, Teva Pharmaceutical Industries' Cash & Current Investments had a median value of $3.2 billion in 2023 and averaged $3.1 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Cash & Current Investments fell by 0.55% in 2021 and then increased by 29.38% in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Cash & Current Investments (MRY) stood at $2.2 billion in 2020, then dropped by 0.55% to $2.2 billion in 2021, then rose by 29.38% to $2.8 billion in 2022, then increased by 15.17% to $3.2 billion in 2023, then rose by 2.29% to $3.3 billion in 2024.
  • Its Cash & Current Investments was $3.3 billion in FY2024, compared to $3.2 billion in FY2023 and $2.8 billion in FY2022.